Search

everythinglearnresearchcommunity

for

Search:↓

International medical graduates scored higher than U.S. graduates on a medical exam.

In 1995, international medical graduates did better than U.S. graduates on a medical exam.

Etanercept may not prevent alopecia areata from coming back.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The document explains how to identify different hair problems using a microscope.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Hair and scalp disorders significantly affect self-esteem, and using cosmetic products like conditioners and styling aids can improve hair health and appearance.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Glycine soja extract stimulates hair growth and could help treat hair loss.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.

Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.